Literature DB >> 10383403

Association of atypical protein kinase C isotypes with the docker protein FRS2 in fibroblast growth factor signaling.

Y P Lim1, B C Low, J Lim, E S Wong, G R Guy.   

Abstract

FRS2 is a docker protein that recruits signaling proteins to the plasma membrane in fibroblast growth factor signal transduction. We report here that FRS2 was associated with PKC lambda when Swiss 3T3 cells were stimulated with basic fibroblast growth factor. PKC zeta, the other member of the atypical PKC subfamily, could also bind FRS2. The association between FRS2 and PKC lambda is likely to be direct as shown by yeast two-hybrid analysis. The C-terminal fragments of FRS2 (amino acid residues 300-508) and SNT2 (amino acids 281-492), an isoform bearing 50% identity to FRS2, interacted with PKC lambda at a region (amino acids 240-562) that encompasses the catalytic domain. In vitro kinase assays revealed neither FRS2 nor SNT2 was a substrate of PKC lambda or zeta. Mutation of the alanine residue (Ala-120) to glutamate in the pseudo-substrate region of PKC lambda results in a constitutively active kinase that exhibited more than 2-fold greater binding to FRS2 in vitro than its "closed" wild-type counterpart. Tyrosine phosphorylation of FRS2 did not affect its binding to the constitutively active PKC lambda mutant, suggesting that the activation of PKC lambda is necessary and sufficient for its association with FRS2. It is likely that FRS2 serves as an anchoring protein for targeting activated atypical PKCs to the cell plasma membrane in signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383403     DOI: 10.1074/jbc.274.27.19025

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Atypical protein kinase Cs are the Ras effectors that mediate repression of myogenic satellite cell differentiation.

Authors:  Yuri V Fedorov; Nathan C Jones; Bradley B Olwin
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

2.  Atypical protein kinase C (iota) activates ezrin in the apical domain of intestinal epithelial cells.

Authors:  Flavia A Wald; Andrea S Oriolo; Anastasia Mashukova; Nevis L Fregien; Amber H Langshaw; Pedro J I Salas
Journal:  J Cell Sci       Date:  2008-02-12       Impact factor: 5.285

Review 3.  Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction.

Authors:  Leanne M Cotton; Moira K O'Bryan; Barry T Hinton
Journal:  Endocr Rev       Date:  2008-01-23       Impact factor: 19.871

4.  Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts.

Authors:  Maryse Delehedde; Malcolm Lyon; John T Gallagher; Philip S Rudland; David G Fernig
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

5.  Upregulation of plasma C9 protein in gastric cancer patients.

Authors:  Poh-Kuan Chong; Huiyin Lee; Marie Chiew Shia Loh; Lee-Yee Choong; Qingsong Lin; Jimmy Bok Yan So; Khong Hee Lim; Ross Andrew Soo; Wei Peng Yong; Siew Pang Chan; Duane T Smoot; Hassan Ashktorab; Khay Guan Yeoh; Yoon Pin Lim
Journal:  Proteomics       Date:  2010-09       Impact factor: 3.984

6.  ITIH3 is a potential biomarker for early detection of gastric cancer.

Authors:  Poh Kuan Chong; Huiyin Lee; Jianbiao Zhou; Shaw-Cheng Liu; Marie Chiew Shia Loh; Ting Ting Wang; Siew Pang Chan; Duane T Smoot; Hassan Ashktorab; Jimmy Bok Yan So; Khong Hee Lim; Khay Guan Yeoh; Yoon Pin Lim
Journal:  J Proteome Res       Date:  2010-07-02       Impact factor: 4.466

7.  Proteome-wide profiling of the MCF10AT breast cancer progression model.

Authors:  Lee Yee Choong; Simin Lim; Poh Kuan Chong; Chow Yin Wong; Nilesh Shah; Yoon Pin Lim
Journal:  PLoS One       Date:  2010-06-09       Impact factor: 3.240

8.  Low molecular weight fibroblast growth factor-2 signals via protein kinase C and myofibrillar proteins to protect against postischemic cardiac dysfunction.

Authors:  Janet R Manning; Sarah O Perkins; Elizabeth A Sinclair; Xiaoqian Gao; Yu Zhang; Gilbert Newman; W Glen Pyle; Jo El J Schultz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-03-11       Impact factor: 4.733

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.